Cogent Biosciences, Inc. (COGT)
32.67
+0.09
(+0.28%)
USD |
NASDAQ |
May 22, 16:00
32.64
-0.02
(-0.08%)
After-Hours: 20:00
Cogent Biosciences EPS Diluted (Quarterly) : -0.60 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Syndax Pharmaceuticals, Inc. | -0.4835 |
| Vera Therapeutics, Inc. | -1.693 |
| Spyre Therapeutics, Inc. | -0.8785 |
| Nuvalent, Inc. | -1.389 |
| Praxis Precision Medicines, Inc. | -3.205 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -97.35M |
| Total Expenses (Quarterly) | 97.35M |
| Enterprise Value | 5.019B |
| Earnings Yield | -7.72% |
| Normalized Earnings Yield | -7.620 |